Biotech Values

[jq1234]

Yervoy monotherapy label - very broad label, doesn't have to be petreated:

YERVOY (ipilimumab) is indicated for the treatment of unresectable or metastatic melanoma.

FDA PR:

SILVER SPRING, Md., March 25, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today approved Yervoy (ipilimumab) to treat patients with late-stage (metastatic) melanoma, the most dangerous type of skin cancer.


http://www.prnewswire.com/news-releases/fda-approves-new-treatment-for-a-type-of-late-stage-skin-cancer-118656794.html